Cite Filings / CTKB / 0001104659-22-028191

Feed Companies Filings Check

Sign in

SC 13D/A

Beneficial Ownership Report

Cytek Biosciences, Inc. Filed 2022-02-28 Acc 0001104659-22-028191

Documents 1

SC 13D/A Beneficial Ownership Report , tm227934d1_sc13da.htm

Around this filing

2022-03-14 SC 13D/A Beneficial Ownership Report
2022-03-02 4 Options or other derivatives
2022-03-02 4 Options or other derivatives
2022-03-02 4 Options or other derivatives
2022-03-02 8-K Executive or director change
2022-03-02 4 Director bought 441,865 shares at an average $12.95 ($5,721,951)
2022-02-28 SC 13D/A Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading tm227934d1_sc13da.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…